Dow Jones 30 Stocks SEC Filings — February 11, 2026

11-02-2026

Energy Vault Holdings, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results with no specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics provided in the filing details. No positive or negative financial performance data is available.

12-02-2026

SOLV Energy, Inc. filed a multi-item Form 8-K on 2026-02-12 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative transaction values, financial impacts, share counts, or performance metrics are disclosed. The filing covers both potentially strategic developments and governance/equity changes with unknown directional implications.

12-02-2026

Coinbase Global, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and attaches relevant exhibits, but no specific revenue, earnings, guidance, or other metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

12-02-2026

West Pharmaceutical Services Inc filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive or negative financial impacts, balance sheet changes, or operational details are available.

11-02-2026

12-02-2026

Baxter International Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007474), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, position, reason for change, timing, financial metrics, or quantitative data are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

Intelligent Bio Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001493152-26-006317), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative financial data were disclosed in the provided filing description. This is a multi-item filing focused on financial results disclosure.

12-02-2026

Vishay Intertechnology Inc filed an 8-K on February 12, 2026 (AccNo: 0000103730-26-000015), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified positive or negative impacts mentioned.

12-02-2026

LIVE VENTURES Inc filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard disclosure for financial results with exhibits attached.

12-02-2026

Flux Power Holdings, Inc. filed an 8-K on 2026-02-12 (AccNo: 0001493152-26-006404, size: 347 KB) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information.

11-02-2026

HomeTrust Bancshares, Inc. filed an 8-K on February 11, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, effective dates, or compensatory terms are disclosed. No financial metrics, quantitative impacts, or other changes are mentioned.

11-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on 2026-02-11 under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals a core delisting event alongside equity sales and disclosures, with no quantitative financial metrics, transaction values, or performance comparisons disclosed. No positive or offsetting metrics are mentioned.

11-02-2026

Ondas Holdings Inc. filed an 8-K on February 11, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a voluntary disclosure likely sharing material non-public information with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the filing metadata. No quantitative data or performance metrics are disclosed.

11-02-2026

Brag House Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015027), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or terms were provided in the filing summary. Sector not specified.

11-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013546, Size: 185 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any financial or compensatory terms are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts were provided in the available information.

11-02-2026

NovoCure Ltd filed an 8-K on February 11, 2026 (AccNo: 0001645113-26-000010, Size: 183 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information with attached exhibits. No financial metrics, transactions, or performance data are specified.

11-02-2026

Qorvo, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000950103-26-001983), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific matters submitted for vote, vote outcomes, tally details, or other numerical results are disclosed. This is purely informational with no financial metrics, changes, or directional implications provided.

11-02-2026

PMGC Holdings Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015003, Size: 212 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the attached exhibits are provided. No financial metrics, transactions, or performance data are disclosed.

11-02-2026

Auburn National Bancorporation, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing is a multi-item disclosure, likely voluntary for Item 8.01, with no specific details on the events, transactions, financial impacts, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or material events are disclosed.

11-02-2026

Evolution Petroleum Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·AccNo: 0001104659-26-013485
• ·File Size: 550 KB

11-02-2026

Tronox Holdings plc filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. Specific details including officer names, positions, reasons for change, or any quantitative data are NOT_DISCLOSED.

11-02-2026

MID PENN BANCORP INC filed an 8-K on February 11, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial impacts, or exhibits are provided in the filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

11-02-2026

La Rosa Holdings Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed.

11-02-2026

Group 1 Automotive Inc filed an 8-K on February 11, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

11-02-2026

Victory Capital Holdings, Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is an informational filing with no quantified metrics, transactions, or impacts mentioned.

11-02-2026

WesBanco Inc filed a Form 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing likely including attached materials such as a press release or presentation given the 27 MB file size. No specific financial metrics, transactions, guidance, or events are disclosed in the provided filing information.

11-02-2026

Navan, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Customers Bancorp, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibit contents are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

11-02-2026

PennyMac Financial Services, Inc. filed an 8-K on February 11, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This appears to be a multi-item filing involving voluntary disclosure of material information under Regulation FD, with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing summary.

11-02-2026

Evergy, Inc. filed a Form 8-K on 2026-02-11 reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). No specific details, dollar values, parties, or impacts are disclosed. This multi-item filing signals changes in agreements and obligations, but lacks quantitative data for assessment.

11-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary provided. This is a multi-item informational filing likely including exhibits such as a press release.

11-02-2026

Richmond Mutual Bancorporation, Inc. filed an 8-K on February 11, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits.

11-02-2026

BankUnited, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001504008-26-000008, Size: 1 MB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific financial metrics, transactions, or performance data disclosed in the provided filing summary. No positive or negative metrics are mentioned.

11-02-2026

Seacoast Banking Corp of Florida filed an 8-K on February 11, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing with attached exhibits, but content is NOT_DISCLOSED.

11-02-2026

Glacier Bancorp, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000868671-26-000013, Size: 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of potentially material non-public information with attached exhibits, such as press releases or presentations. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing summary.

11-02-2026

Aptiv PLC filed a Form 8-K on February 11, 2026, under Item 8.01 reporting Other Events. No specific details regarding the core event, financial impacts, transactions, metrics, or quantitative data are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

11-02-2026

INTERNATIONAL FLAVORS & FRAGRANCES INC filed a Form 8-K on 2026-02-11 reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided filing summary. No positive or negative performance indicators, guidance, or scheduled events were mentioned.

11-02-2026

Apple iSports Group, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001477932-26-000755), reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, parties, dollar value, strategic role, or financial implications were disclosed. This is a single-item mandatory disclosure with no other metrics or comparisons provided.

11-02-2026

Bravo Multinational Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for change, or compensation are disclosed.

11-02-2026

Service Corp International filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007289), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available for analysis.

11-02-2026

Aurora Innovation, Inc. filed an 8-K on February 11, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard multi-item earnings-related disclosure.

11-02-2026

Q2 Holdings, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

11-02-2026

National Bank Holdings Corp filed a Form 8-K on February 11, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, along with Regulation FD disclosure in Item 7.01 and exhibits in Item 9.01. No quantitative details such as transaction values, financial terms, or impacts on revenue, earnings, balance sheet, or guidance are disclosed. This multi-item filing signals significant contractual and financing activity but provides no metrics for positive or negative assessment.

11-02-2026

Abpro Holdings, Inc. filed a Form 8-K on 2026-02-11 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which is a material negative event signaling potential loss of exchange trading status. The filing is multi-item, also disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative financial metrics, transaction values, or other numerical data are disclosed.

11-02-2026

Balance Labs, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the affected position, appointment or resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or additional corporate actions were mentioned.

11-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-11 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities). This multi-item filing indicates a likely financing-related transaction involving a new agreement, financial obligation, and equity issuance, but no quantitative details, terms, or impacts are disclosed. No positive or negative metrics, comparisons, or guidance changes are provided.

11-02-2026

Palomar Holdings, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 to report results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed metrics available.

11-02-2026

Intuitive Machines, Inc. filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are explicitly stated. No positive or negative metrics, financial impacts, or scheduled events were mentioned.

11-02-2026

INDEPENDENT BANK CORP filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details from the exhibits or disclosure content are missing.

11-02-2026

Mativ Holdings, Inc. filed an 8-K on 2026-02-11 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions affected, reasons for change, or quantitative data are disclosed.

11-02-2026

M&T Bank Corp filed an 8-K on February 11, 2026 (AccNo: 0000036270-26-000007, size 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure, likely attaching materials such as a press release or presentation, but specific content, financial metrics, transactions, or events are NOT_DISCLOSED. No positive or negative metrics are provided.

11-02-2026

Gladstone Investment Corporation filed an 8-K on February 11, 2026, reporting under Item 1.01 its entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details regarding the agreement's parties, terms, value, financial impacts, or any quantitative metrics are provided.

11-02-2026

AppLovin Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings release filing with attached financial statements.

11-02-2026

Cisco Systems, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are mentioned.

11-02-2026

Viking Therapeutics, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046536), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure for financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided information. No positive or negative metrics are available for balanced assessment.

11-02-2026

Vanda Pharmaceuticals Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition and Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure typical for quarterly financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary.

11-02-2026

Southern California Edison Co filed an 8-K on 2026-02-11 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

11-02-2026

CoreCivic, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046527), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

11-02-2026

Gouverneur Bancorp, Inc./MD/ filed an 8-K on February 11, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, vote results, attendance, or outcomes are provided in the filing summary. This is purely informational with no financial metrics, changes, or directional implications disclosed.

11-02-2026

Dakota Gold Corp. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013353, Size: 564 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional impacts mentioned.

11-02-2026

McDonald's Corp filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or strategic updates are mentioned.

11-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

11-02-2026

Amerant Bancorp Inc. filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or directional impacts are detailed in the provided filing information. All quantitative data, guidance, and operational details are NOT_DISCLOSED.

11-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed a Form 8-K on February 11, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, voluntary disclosure.

11-02-2026

Virtuix Holdings Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned.

11-02-2026

Alaska Silver Corp. filed a Form 8-K on February 11, 2026 (AccNo: 0001062993-26-000786), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information to comply with Regulation FD, with exhibits attached, but no specific details on events, metrics, or transactions are provided in the filing header. No quantitative data, positive or negative metrics, or performance comparisons are mentioned.

12-02-2026

Avient Corp filed an 8-K on February 12, 2026 (AccNo: 0001122976-26-000035), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but specific revenue, earnings, margins, or other metrics are NOT_DISCLOSED. No period-over-period comparisons, guidance, or balance sheet details are provided in the filing summary.

12-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001062993-26-000822, Size: 587 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction values, financial metrics, or performance comparisons disclosed in the provided information. No quantitative data, period-over-period changes, positive or negative metrics, or strategic implications are available.

12-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047540), reporting under Item 1.02 the termination of a material definitive agreement. No financial terms, parties involved, strategic rationale, or impacts are disclosed.

12-02-2026

NovaBay Pharmaceuticals, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial impacts, transactions, or exhibits are disclosed in the provided filing information. The filing appears informational without quantified metrics or directional implications.

12-02-2026

PG&E Corp filed an 8-K on February 12, 2026 (AccNo: 0001004980-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, guidance, or other numerical data in the available description. No positive or negative performance indicators are detailed.

12-02-2026

Bally's Corp filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or content of the exhibits are disclosed in the filing summary. No financial metrics, transactions, or directional impacts are mentioned.

12-02-2026

Vontier Corp filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007456), reporting under Item 2.02 Results of Operations and Financial Condition, with exhibits under Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This appears to be a standard mandatory disclosure for financial results.

12-02-2026

FTAI Aviation Ltd. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions, reasons for changes, timing, or quantitative details such as compensation amounts were provided. No positive or negative metrics, performance context, or governance implications were mentioned.

12-02-2026

TripAdvisor, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-047622), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or quantitative metrics were explicitly stated in the filing metadata provided. Sector information is not specified.

12-02-2026

Arvinas, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007463), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This represents a standard disclosure requirement without additional context on positive or negative implications.

12-02-2026

ConnectOne Bancorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001437749-26-003852, size: 4 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of any financial statements/exhibits are disclosed. This appears to be a multi-item voluntary disclosure with attached materials.

12-02-2026

Iridium Communications Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001418819-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing disclosing financial results with attached exhibits. No specific revenue, earnings, margins, or period-over-period metrics are detailed in the provided filing information.

12-02-2026

Sylvamo Corp filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative metrics were disclosed in the provided filing details. This constitutes a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

ADVANCED DRAINAGE SYSTEMS, INC. filed an 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, or operational details are disclosed in the filing summary. The disclosure appears informational with no mentioned positive or negative impacts.

12-02-2026

Kelly Services Inc filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

12-02-2026

Optimum Communications, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

12-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of material non-public information with attached exhibits, but no specific transaction details, financial metrics, or operational data are mentioned. Critical content of the disclosure is missing from the provided summary.

12-02-2026

Ryan Specialty Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 Other Events. No financial metrics, transaction details, quantitative data, or specific events were disclosed in the filing summary provided. This is an informational disclosure with no apparent positive or negative financial impacts mentioned.

12-02-2026

Avadel Pharmaceuticals PLC filed an 8-K on 2026-02-12 disclosing the completion of an acquisition or disposition of assets under Item 2.01, changes in control of the registrant under Item 5.01, and notice of delisting or failure to satisfy listing standards under Item 3.01. The filing also reports termination of a material definitive agreement (Item 1.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties, or specific terms were disclosed.

12-02-2026

LiveRamp Holdings, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0000733269-26-000017, Size: 164 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure, but details of the core events or exhibits are NOT_DISCLOSED.

12-02-2026

Theriva Biologics, Inc. filed an 8-K on February 12, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transaction values, or metrics are disclosed in the filing summary. No positive or negative metrics are mentioned.

12-02-2026

IPG Photonics Corp filed an 8-K on 2026-02-12 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.

12-02-2026

Voyager Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, appointment or resignation, reasons, timing, or any quantitative data such as compensation amounts or share counts are disclosed. Sector is not specified.

12-02-2026

Evolv Technologies Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Seagate Technology Holdings plc filed an 8-K on February 12, 2026, reporting multiple items including Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or quantitative data disclosed in the provided information. No positive or negative performance metrics are mentioned.

12-02-2026

Aardvark Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it is an appointment or resignation, reasons for the change, named individuals, effective dates, or any quantitative data such as compensation amounts are disclosed. No financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

12-02-2026

VerifyMe, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a new material definitive agreement (Item 1.01) while simultaneously terminating another material definitive agreement (Item 1.02), alongside changes involving departure or election of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial details, transaction values, or specific impacts are provided in the filing summary. Item 9.01 lists financial statements and exhibits, but contents are not detailed.

12-02-2026

Xerox Holdings Corp filed a Form 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the available filing summary.

12-02-2026

FIRST NATIONAL CORP /VA/ filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No quantitative metrics, transactions, or financial impacts are mentioned.

12-02-2026

Ballston Spa Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.

12-02-2026

Knight-Swift Transportation Holdings Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the other events, transaction values, financial metrics, or exhibits disclosed in the provided filing summary. No positive, negative, or flat performance metrics are mentioned.

12-02-2026

Annovis Bio, Inc. filed a Form 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing indicating voluntary public release of material information to comply with Regulation FD, with exhibits likely attached such as a press release. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

12-02-2026

Lincoln Electric Holdings Inc filed an 8-K on February 12, 2026 (AccNo: 0000059527-26-000003, Size: 1 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

SAGA COMMUNICATIONS INC filed a Form 8-K on February 12, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events or the contents of the exhibits are provided. All quantitative data, transaction details, and financial impacts are NOT_DISCLOSED.

12-02-2026

INNOVATIVE SOLUTIONS & SUPPORT INC filed an 8-K on February 12, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing details. This appears to be a standard voluntary earnings announcement without detailed performance highlights.

12-02-2026

Aspire Biopharma Holdings, Inc. filed a multi-item Form 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

BION ENVIRONMENTAL TECHNOLOGIES INC filed an 8-K on February 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transaction values, financial metrics, or exhibits provided. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

12-02-2026

Magyar Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, positive or negative changes, or other quantitative details are disclosed.

12-02-2026

FVCBankcorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001675644-26-000006, size: 25 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or specific terms are disclosed.

• ·Multi-item 8-K filing (5 items reported)
• ·File size: 25 MB (suggests detailed exhibits)

12-02-2026

Direct Digital Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The core event or details of the 'Other Events' and contents of the exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are specified in the filing summary.

12-02-2026

FIRST US BANCSHARES, INC. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.

12-02-2026

Tennessee Valley Authority filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance metrics are mentioned.

12-02-2026

VASO Corp filed an 8-K on February 12, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details, financial metrics, positive or negative changes, or quantitative impacts are provided in the filing summary.

12-02-2026

Kentucky First Federal Bancorp filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015539), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This represents a standard voluntary earnings-related disclosure with no specific revenue, earnings, balance sheet changes, or period-over-period comparisons detailed in the provided filing information. No positive or negative financial metrics were quantified.

12-02-2026

MIAMI INTERNATIONAL HOLDINGS, INC. filed an 8-K on February 12, 2026, reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, recipients, or pricing were disclosed. This disclosure is informational without specified financial or strategic context.

12-02-2026

Verses AI Inc. filed an 8-K on 2026-02-12 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for change, or any quantitative metrics are provided. No positive or negative performance metrics mentioned.

12-02-2026

Kenvue Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

• ·Filing Accession Number: 0000950157-26-000133
• ·File Size: 155 KB
• ·Sector: NOT_DISCLOSED

12-02-2026

Phillips Edison & Company, Inc. filed an 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are detailed in the filing summary provided. Critical details of the disclosure are missing, limiting assessment of impact.

12-02-2026

Fathom Holdings Inc. filed a Form 8-K on February 12, 2026, reporting Changes in Control of Registrant under Item 5.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing indicates a potentially material governance event but provides no specific details on the nature of the control change, transaction terms, or financial impacts. No quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are disclosed.

12-02-2026

Quaint Oak Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details, financial metrics, dollar values, or impacts are provided.

12-02-2026

Repay Holdings Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

Hennessy Capital Investment Corp. VIII filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits provided in the summary. No financial metrics, transactions, or impacts are disclosed.

12-02-2026

Vertex Pharmaceuticals Inc. / MA filed a Form 8-K on February 12, 2026 (AccNo: 0000875320-26-000034), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, balance sheet details, or other quantitative metrics were explicitly stated. No positive, negative, or flat performance indicators were disclosed.

12-02-2026

Walt Disney Co filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative financial metrics, positive or negative developments, or performance comparisons mentioned.

12-02-2026

Rivian Automotive, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results typically accompanying an earnings release. This is a multi-item filing with no specific revenue, earnings, balance sheet effects, guidance, or other quantitative metrics explicitly stated in the provided information. No positive, negative, or flat performance indicators are disclosed.

12-02-2026

12-02-2026

Capstone Green Energy Holdings, Inc. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

12-02-2026

CVR Energy Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This multi-item filing signals a significant contractual commitment and new financial liability, but no details on terms, size, or impacts are provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

12-02-2026

VenHub Global, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015576), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction values, financial metrics, or performance comparisons disclosed. No positive or negative metrics are provided.

12-02-2026

Fortune Brands Innovations, Inc. filed an 8-K on February 12, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, timing, and any financial metrics are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or quantitative data are provided in the filing summary.

12-02-2026

Catheter Precision, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). While the material agreement may signal strategic progress, the unregistered equity sales raise potential dilution concerns and the governance changes introduce uncertainty without specified details. No quantitative transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

12-02-2026

Bain Capital GSS Investment Corp. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

AVITA Medical, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. The filing size is 518 KB with Accession Number 0001193125-26-048761.

• ·Filing Accession Number: 0001193125-26-048761
• ·Filing size: 518 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

12-02-2026

FrontView REIT, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048763), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or guidance changes are mentioned.

12-02-2026

Presurance Holdings, Inc. filed a Form 8-K on February 12, 2026, under Item 8.01 disclosing Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are provided in the filing summary. No positive, negative, or flat metrics are mentioned.

12-02-2026

ARTIVION, INC. filed a Form 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure without performance data available for analysis.

• ·AccNo: 0001628280-26-007674
• ·Filing size: 698 KB
• ·Event Type: Financial Results
• ·Source: us_sec

12-02-2026

NMI Holdings, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Norwegian Cruise Line Holdings Ltd. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.

12-02-2026

Grand Canyon Education, Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

CVRx, Inc. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.

12-02-2026

MVB Financial Corp filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative details are mentioned in the filing description. This is a standard earnings-related disclosure for a financial institution.

12-02-2026

Vistagen Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007715), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This is a standard multi-item disclosure for financial results.

12-02-2026

Morningstar, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001289419-26-000009, Size: 8 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, margins, or period-over-period comparisons are explicitly stated. No positive or negative metrics are detailed in the provided filing information.

12-02-2026

Visa Inc. filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing information.

12-02-2026

Farmers & Merchants Bancorp filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other event, any financial statements, or exhibits are NOT_DISCLOSED in the provided filing summary. No quantitative metrics, comparisons, or directional changes are mentioned.

12-02-2026

LiveOne, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided information. This is a multi-item filing related to financial results announcement.

12-02-2026

Farmers & Merchants Bancorp Inc filed a Form 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing summary. No period-over-period comparisons, guidance, or material impacts are mentioned.

12-02-2026

Carnival PLC filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders, with exhibits provided under Item 9.01. No specific details, financial terms, quantitative metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the filing summary. This is a multi-item mandatory filing with no further transaction or impact data available.

12-02-2026

Middlefield Banc Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

12-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-12 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative metrics are available.

12-02-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, or guidance were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance indicators.

12-02-2026

Republic Services, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with no specific details on the officer, position, or reason provided. The filing also covers Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), filed under AccNo: 0001060391-26-000066 (size: 540 KB). No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing AccNo: 0001060391-26-000066
• ·File Size: 540 KB
• ·Event Date: 2026-02-12
• ·Sector: NOT_DISCLOSED

12-02-2026

Topgolf Callaway Brands Corp. filed an 8-K on February 12, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

12-02-2026

Vail Resorts Inc filed an 8-K on February 12, 2026 (AccNo: 0000812011-26-000010), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or other performance data are mentioned.

12-02-2026

Coeptis Therapeutics Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for change, timing, or any financial metrics are disclosed. No quantitative data or period-over-period comparisons provided.

12-02-2026

Cantor Equity Partners VI, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

12-02-2026

12-02-2026

SafeSpace Global Corp filed a Form 8-K on February 12, 2026, specifically under Item 7.01 Regulation FD Disclosure. This single-item voluntary filing discloses material non-public information previously shared selectively, but no financial metrics, transactions, or other quantitative details are provided. No positive or negative performance indicators are mentioned.